Executive functioning in cognitively normal middle-aged offspring of late-onset Alzheimer's disease patients

被引:12
|
作者
Abulafia, Carolina [1 ,4 ]
Fiorentini, Leticia [1 ,2 ,4 ]
Loewenstein, David A. [5 ,6 ]
Curiel-Cid, Rosie [5 ,6 ]
Sevlever, Gustavo [7 ,8 ]
Nemeroff, Charles B. [9 ]
Villarreal, Mirta F. [1 ,2 ,10 ]
Vigo, Daniel E. [2 ,3 ,11 ]
Guinjoan, Salvador M. [1 ,2 ,4 ,12 ]
机构
[1] FLENI, Grp Invest Neurociencias Aplicadas Alteraciones C, Buenos Aires, DF, Argentina
[2] Consejo Nacl Invest Cient & Tecn, Natl Council Sci & Technol Res, Buenos Aires, DF, Argentina
[3] Univ Catolica Argentina, Sch Med Sci, Inst Biomed Res BIOMED, Buenos Aires, DF, Argentina
[4] FLENI, Serv Psiquiat, Buenos Aires, DF, Argentina
[5] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Coral Gables, FL 33124 USA
[6] Univ Miami, Miller Sch Med, Ctr Aging, Coral Gables, FL 33124 USA
[7] FLENI, Dept Neuropatol & Biol Mol, Buenos Aires, DF, Argentina
[8] FLENI, Dept Docencia & Invest, Buenos Aires, DF, Argentina
[9] Univ Texas Austin, Dell Med Sch, Inst Early Life Advers Res, Austin, TX 78712 USA
[10] Univ Buenos Aires, Dept Phys FCEyN, Buenos Aires, DF, Argentina
[11] Katholieke Univ Leuven, Sch Psychol & Educ Sci, Leuven, Belgium
[12] Univ Buenos Aires, Fac Med, Unidad Docente FLENI, Dept Psiquiat & Salud Mental, Buenos Aires, DF, Argentina
关键词
Preclinical late-onset Alzheimer's disease; RAVLT; Executive functions; Process scores; Subtle cognitive changes; PROACTIVE SEMANTIC INTERFERENCE; FUNCTION DEFICITS; IMPAIRMENT; DYSFUNCTION; VARIABLES; PROFILE; LIFE;
D O I
10.1016/j.jpsychires.2019.02.016
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Episodic memory deficits are traditionally seen as the hallmark cognitive impairment during the prodromal continuum of late-onset Alzheimer's disease (LOAD). Previous studies identified early brain alterations in regions subserving executive functions in asymptomatic, middle-aged offspring of patients with LOAD (O-LOAD), suggesting that premature episodic memory deficits could be associated to executive dysfunction in this model. We hypothesized that O-LOAD would exhibit reduced executive performance evidenced by increased errors and decreased strategy use on an episodic memory task. We assessed 32 asymptomatic middle-aged O-LOAD and 28 age-equivalent control subjects (CS) with several tests that measure executive functions and the Rey Auditory Verbal Learning Test (RAVLT) to measure memory performance. All tests were scored using both traditional and process scores (quantification of errors and strategies underlying overall performance). T-tests were used to compare performance between both groups and Spearman correlations were implemented to measure associations between variables. O-LOAD participants exhibited decreased executive performance compared to CS as it relates to initiation time (Tower of London), mental switching (Trail Making Test B), and interference effects (Stroop Word-Color condition). Traditional RAVLT measures showed a poorer performance by O-LOAD and RAVLT process scores revealed increased interference effects on this group. Positive correlations (r(s)) were found between the executive measures and several RAVLT measures for O-LOAD but not for CS. In conclusion, O-LOAD participants exhibited early subtle cognitive changes in executive processing. Observed memory difficulties may be associated in part to executive deficits suggesting an interplay between memory and executive functions. Process score impairments were observed earlier than clinical decline on neuropsychological scores in this at-risk cohort and might be useful cognitive markers of preclinical LOAD.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [41] Whole Genome-Sequencing in Parent-Offspring Trios with Late-Onset Alzheimer's Disease
    Vardarajan, Badri
    Reyes-Dumeyer, Dolly
    Tosto, Giuseppe
    Rodriguez-Barral, Sandra
    Lantigua, Rafael A.
    Mayeux, Richard
    ANNALS OF NEUROLOGY, 2018, 84 : S66 - S66
  • [42] Alzheimer's disease murine models: focus on late-onset disease
    Potenza, M. A.
    Nacci, C.
    Carratu, M. R.
    DRUGS OF THE FUTURE, 2020, 45 (02) : 109 - 117
  • [43] Plasma cholesterol and risk for late-onset Alzheimer's disease
    Cedazo-Minguez, Angel
    Ismail, Muhammad-Al-Mustafa
    Mateos, Laura
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (04) : 495 - 498
  • [44] Search for late-onset familial Alzheimer's disease genes
    Schellenberg, GD
    Yu, CE
    Steinbart, EJ
    Bird, TD
    Wijsman, EM
    Daw, EW
    Payami, H
    Conlon, EM
    Nochlin, D
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S10 - S10
  • [45] The 'eye test' in recognition of late-onset Alzheimer's disease
    Caputo, L
    Casartelli, M
    Perrone, C
    Santori, M
    Annoni, G
    Vergani, C
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1998, 27 (02) : 171 - 177
  • [46] α2-macroglobulin in late-onset Alzheimer's disease
    Kovacs, DM
    EXPERIMENTAL GERONTOLOGY, 2000, 35 (04) : 473 - 479
  • [47] Neuropathology of preclinical and clinical late-onset Alzheimer's disease
    Troncoso, JC
    Cataldo, AM
    Nixon, RA
    Barnett, JL
    Lee, MK
    Checler, F
    Fowler, DR
    Smialek, JE
    Crain, B
    Martin, LJ
    Kawas, CH
    ANNALS OF NEUROLOGY, 1998, 43 (05) : 673 - 676
  • [48] Early and late-onset Alzheimer's disease: What are the differences?
    Awada, Adnan A.
    JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2015, 6 (03) : 455 - +
  • [49] Assessment of the genetic variance of late-onset Alzheimer's disease
    Ridge, Perry G.
    Hoyt, Kaitlyn B.
    Boehme, Kevin
    Mukherjee, Shubhabrata
    Crane, Paul K.
    Haines, Jonathan L.
    Mayeux, Richard
    Farrer, Lindsay A.
    Pericak-Vance, Margaret A.
    Schellenberg, Gerard D.
    Kauwe, John S. K.
    NEUROBIOLOGY OF AGING, 2016, 41
  • [50] Late-onset Alzheimer's disease associated to NEPRILYSIN gene
    Clarimón, J
    Bertranpetit, J
    Boada, M
    Tarraga, L
    Comas, D
    NEUROLOGY, 2002, 58 (07) : A41 - A41